目前的情况和有关日本风险管理计划终止的问题
Natsuko Kameyama1, Aoi Hosaka2, Hideki Maeda1,2
1Department of Regulatory Science, Graduate School of Pharmaceutical Science, Meiji Pharmaceutical University, Tokyo, Japan.
Frontiers in medicine
|June 14, 2024
概括
在日本,大多数药物的风险管理计划 (RMP) 在重新审查后被终止. 然而,一些已终止的RMP仍然存在未列出的风险,这凸显了关于终止后药物安全性的更明确指导方针的需要.
科学领域:
- 药监和药物安全 药监和药物安全
- 监管科学 监管科学
- 制药政策 制药政策
背景情况:
- 2013年实施的日本风险管理计划 (RMP) 系统允许在重新审查时对RMP终止进行评估.
- 1979年建立的重新审查系统评估了药物营销后的疗效和安全性.
- 在RMP终止后风险管理的指导方针仍然不清楚,这带来了潜在的安全挑战.
研究的目的:
- 调查在日本的药物的特征,其RMP要求在重新审查后被取消.
- 为了确定在重新检查后仍有RMP要求的药物.
- 分析对药物安全管理和未来政策的影响.
主要方法:
- 对2013年以后批准的RMP的药物进行了回顾性分析.
- 关于RMP终止状态的数据来自制药和医疗器械局 (PMDA) 网站.
- 该研究涵盖了从2013年4月到2023年3月的10年时间.
主要成果:
- 在完成重新检查的72种药物中,69种RMP (95.8%) 被终止.
- 在已终止的RMP中,23.2%有未列出的潜在风险 (例如恶性瘤),15.9%有未列出的缺失信息 (例如心血管影响).
- 很大一部分 (62.3%) 在终止后仍有风险最小化活动.
结论:
- 在日本,大多数RMP在重新审查后终止,但这可能会让安全问题没有得到解决.
- 需要更明确的法规,以便在RMP终止后继续进行风险管理.
- 加强药物安全管理至关重要,尤其是在全球协调工作中.
相关概念视频
Types of Reports II: Incident or Occurrence Report
818
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
818
Actuarial Approach
74
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
74
Methods of Documentation VI: Case Management Model
567
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
567
Ethical Dilemmas II
988
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
988
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Hazard Ratio
111
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
111


